Navigation Links
Digitek Medication Recalled Due to Risk of Digitalis Toxicity
Date:8/18/2009

EDISON, N.J.,, Aug. 18 /PRNewswire/ -- Digitek Medication: Digitek (digoxin tablets) is a widely-used medication used to treat various heart conditions, such as abnormal heart rhythms (atrial fibrillation & atrial flutter), and heart failure. Digitek is a powerful drug, which is so potent that even a slight increase in dosage can be toxic or fatal.

If you or a loved one has suffered digitalis toxicity or symptoms associated with digitalis toxicity as a result of taking Digitek, you should contact Eichen Levinson & Crutchlow (http://www.eichenlevinson.com/) to evaluate your claim. You may be entitled to compensation for medical expenses, loss of wages, and pain and suffering. Eichen's Digitek attorneys are able to handle and litigate Digitek cases no matter where you live

Digitek Recall: Following repeated Food and Drug Administration (FDA) criticisms of its manufacturing processes, the pharmaceutical company, Actavis Totowa issued a Class I nationwide drug recall for all lots of Digitek (digoxin) on the grounds that some tablets may contain twice the approved level of the active ingredient. A Class I recall is the most dangerous type of FDA recall. Even though the drugs are sold under different brand names, they are essentially the same product with the same active ingredient. Therefore, the recall pertains to Digitek tablets (all strengths) distributed by Mylan Pharmaceuticals and sold under the label "Bertek", as well as Digitek distributed by UDL Laboratories, Inc. and sold under the label "UDL".

Digitalis Toxicity Signs & Symptoms may include the following:

  • Visual changes, for example
    • Halos or rings of light around objects
    • Seeing lights or bright spots
    • Changes in color perception
    • Blind spots in vision
    • Blurred vision
  • Confusion
  • Loss of appetite
  • Nausea, vomiting, diarrhea
  • Palpitations
  • Irregular Pulse
  • Decreased urine output
  • Excessive nighttime urination
  • Overall Swelling
  • Decreased consciousness
  • Difficulty breathing when lying down

To evaluate your Digitek claim, contact Eichen Levinson & Crutchlow, with offices located in Edison, New Jersey and Toms River, New Jersey, provides award-winning legal services in the tri-state area and nationally in matters involving catastrophic personal injury, mass torts, medical malpractice, class actions, and consumer fraud litigation.

    Contact: Angela McKillop
    Amckillop@eichenlevinson.com
    EichenLevinson .com
    Tel: (732) 777-0100
    Fax: (732) 248-8273


'/>"/>
SOURCE Eichen Levinson & Crutchlow, LLP
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. US Drug Watchdog Expands Its National Investigation Into The Drug Called Digitek, And Would Like To Talk To Possible Victims
2. National Class Action Filed Against Manufacturer of Digitek(R) (Prescription Drug) in Federal Court in Michigan
3. Hissey Kientz Concerned That Patients Have Not Been Provided With Crucial Information About Digitek Recall Despite the Dangers of Digoxin Toxicity
4. Hissey Kientz, LLP Announces the Launch of Digitek Recall Help Web Site
5. APA Comments on FDAs First Approval of Medication to Treat Pediatric Schizophrenia and Bipolar Disorder
6. Manic phase of bipolar disorder benefits from breast cancer medication
7. AHRQ and FDA to Collaborate in Largest Study Ever of Possible Heart Risks with ADHD Medications
8. Mayo Clinic study indicates medication for ADHD may help student outcomes
9. Diet and medications may assist prevention of prostate cancer
10. Delmarva Foundation Implements Medication Therapy Management Program in Maryland and DC
11. Patient Safety Authority Releases Advisory Focusing on Common Causes of Medication Errors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/16/2017)... (PRWEB) , ... January 17, 2017 , ... Recently, patients ... in Southwest Michigan, joined other volunteers and organizations in support of the annual Binder ... children and families dressed up in colorful costumes of all designs coming out to ...
(Date:1/16/2017)... (PRWEB) , ... January 16, 2017 , ... ... products, will demonstrate their groundbreaking GunSport•PRO® and EB15•LE® electronic earplugs at the NSSF ... in Las Vegas, Booth #2809. The SHOT Show is the shooting, hunting and ...
(Date:1/16/2017)... ... January 16, 2017 , ... Houston dentist, ... is currently offering complimentary consultations and financing for orthodontics for a limited time. ... irregularities and learn about their orthodontic options. Walk-in, late-evening, Saturday, and same-day appointments ...
(Date:1/16/2017)... ... 2017 , ... Specialty Technical Publishers (STP) and Specialty Technical ... (IAPC) EHS audit protocol for Singapore . Leading companies around the world ... obligations and rapidly collect, share, archive, and export audit findings in a cost ...
(Date:1/16/2017)... ... January 16, 2017 , ... Date aired: ... http://www.ageofautism.com/legal , Sharon Kleyne, America’s leading water educator, researcher and advocate welcomed ... radio program, The Sharon Kleyne Hour Power of Water, Global Climate Change and ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... , Jan 17, 2017 Research and ... Market 2016-2020" report to their offering. ... The global laparotomy sponges market to ... Global Laparotomy Sponges Market 2016-2020, has been prepared ... The report covers the market landscape and its growth prospects over ...
(Date:1/17/2017)...  ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ... Quinn Ph.D as Vice President Corticotropin Regulatory Affairs, ... Karen Quinn is a professional with over ... Affairs, specifically with a focus on drug products ... most recently with Takeda Pharmaceuticals International as Senior ...
(Date:1/17/2017)... , Jan. 17, 2017  Bayer today announced the appointment ... Pharmaceuticals business in the Americas, comprising the United ... Latin America . In this role, Dr. ... the Board of Management of Bayer AG and President of ... highly respected leader in the pharmaceutical industry and I,m delighted ...
Breaking Medicine Technology: